Pragya Yadav to Toll-Like Receptor 7
This is a "connection" page, showing publications Pragya Yadav has written about Toll-Like Receptor 7.
Connection Strength
0.041
-
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial. Lancet Infect Dis. 2021 05; 21(5):637-646.
Score: 0.041
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.